Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP170825.RA4U2sR3CSesvzK15DmepzRhYt-2m7sZT4QlsQExiLrAw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP170825.RA4U2sR3CSesvzK15DmepzRhYt-2m7sZT4QlsQExiLrAw130_assertion type Assertion NP170825.RA4U2sR3CSesvzK15DmepzRhYt-2m7sZT4QlsQExiLrAw130_head.
- NP170825.RA4U2sR3CSesvzK15DmepzRhYt-2m7sZT4QlsQExiLrAw130_assertion description "[Cross-talk between AKT and estrogen receptor beta-mediated transcription pathways may represent an important aspect that may influence breast cancer response to endocrine therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP170825.RA4U2sR3CSesvzK15DmepzRhYt-2m7sZT4QlsQExiLrAw130_provenance.
- NP170825.RA4U2sR3CSesvzK15DmepzRhYt-2m7sZT4QlsQExiLrAw130_assertion evidence source_evidence_literature NP170825.RA4U2sR3CSesvzK15DmepzRhYt-2m7sZT4QlsQExiLrAw130_provenance.
- NP170825.RA4U2sR3CSesvzK15DmepzRhYt-2m7sZT4QlsQExiLrAw130_assertion SIO_000772 16951146 NP170825.RA4U2sR3CSesvzK15DmepzRhYt-2m7sZT4QlsQExiLrAw130_provenance.
- NP170825.RA4U2sR3CSesvzK15DmepzRhYt-2m7sZT4QlsQExiLrAw130_assertion wasDerivedFrom lhgdn-20090331 NP170825.RA4U2sR3CSesvzK15DmepzRhYt-2m7sZT4QlsQExiLrAw130_provenance.
- NP170825.RA4U2sR3CSesvzK15DmepzRhYt-2m7sZT4QlsQExiLrAw130_assertion wasGeneratedBy ECO_0000203 NP170825.RA4U2sR3CSesvzK15DmepzRhYt-2m7sZT4QlsQExiLrAw130_provenance.